01942.HK
MOG Holdings Limited
HKSE · Healthcare · Medical - Instruments & Supplies · MY
HKD 0.06
−3.23%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 375.7M | 495.4M | 812.1M | 919.8M | 467.0M |
| Cost of Revenue | 277.8M | 397.6M | 709.8M | 786.5M | 336.6M |
| Gross Profit | 97.9M | 97.9M | 102.3M | 133.3M | 130.4M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 133.3M | 125.5M | 116.5M | 119.5M | 146.2M |
| General & Admin Expense | 80.3M | 64.4M | 47.0M | 33.0M | 69.3M |
| Selling & Marketing Expense | 44.0M | 61.1M | 69.6M | 86.4M | 75.8M |
| Other Expenses | 68.3M | 13.0M | 4.3M | 10.7M | 3.6M |
| Total Operating Expenses | 201.7M | 138.5M | 120.8M | 130.2M | 149.8M |
| Cost and Expenses | 451.2M | 536.1M | 830.7M | 916.7M | 486.3M |
| Operating Income (EBIT) | (88.5M) | (40.7M) | (18.6M) | 3.1M | (19.4M) |
| Non-Operating | |||||
| Interest Income | 3.0M | 2.4M | 887.6K | 3.0M | 1.7M |
| Interest Expense | 1.3M | 1.3M | 2.8M | 2.9M | 658.0K |
| Net Interest Income | 2.5M | 1.1M | (1.9M) | 109.5K | 993.2K |
| Other Non-Op Income/Expense | (8.4M) | (9.0M) | (79.1M) | (48.2M) | 7.4M |
| Non-Operating Income (excl Interest) | 1.8M | 7.7M | 76.3M | 45.3M | — |
| EBT (Pre-Tax Income) | (69.9M) | (49.7M) | (97.7M) | (45.1M) | (11.9M) |
| Income Tax Expense | 4.4M | 3.6M | (5.4M) | 3.1M | 8.0M |
| Bottom Line | |||||
| Net Income | (73.5M) | (52.6M) | (92.8M) | (49.0M) | (23.7M) |
| Earnings from Cont. Ops | (73.4M) | (53.3M) | (92.3M) | (48.2M) | (19.9M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (109.4M) | (52.6M) | (92.8M) | (49.0M) | (23.7M) |
| Per Share | |||||
| Basic EPS | (HK$0.08) | (HK$0.04) | (HK$0.11) | (HK$0.07) | (HK$0.04) |
| Diluted EPS | (HK$0.08) | (HK$0.04) | (HK$0.11) | (HK$0.07) | (HK$0.04) |
| Revenue Per Share | HK$0.27 | HK$0.41 | HK$0.94 | HK$1.33 | HK$0.86 |
| Shares | |||||
| Basic Shares Outstanding | 1.4B | 1.2B | 861.1M | 689.7M | 542.1M |
| Diluted Shares Outstanding | 1.4B | 1.2B | 861.1M | 689.7M | 542.1M |
| Profitability Metrics | |||||
| EBITDA | (58.4M) | (33.5M) | (76.8M) | (24.2M) | (2.0M) |
| D&A | 20.8M | 14.9M | 18.1M | 18.0M | 17.4M |
| EBIT | (79.2M) | (48.4M) | (94.8M) | (42.2M) | (19.3M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026